289 related articles for article (PubMed ID: 25893253)
1. Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.
Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Bose S; Lees AJ; Piccini P
J Neurol; 2015 Jun; 262(6):1504-14. PubMed ID: 25893253
[TBL] [Abstract][Full Text] [Related]
2. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
3. Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders.
Lee JY; Seo SH; Kim YK; Yoo HB; Kim YE; Song IC; Lee JS; Jeon BS
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):23-30. PubMed ID: 24023269
[TBL] [Abstract][Full Text] [Related]
4. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.
O'Sullivan SS; Wu K; Politis M; Lawrence AD; Evans AH; Bose SK; Djamshidian A; Lees AJ; Piccini P
Brain; 2011 Apr; 134(Pt 4):969-78. PubMed ID: 21349901
[TBL] [Abstract][Full Text] [Related]
5. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.
Voon V; Rizos A; Chakravartty R; Mulholland N; Robinson S; Howell NA; Harrison N; Vivian G; Ray Chaudhuri K
J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):148-52. PubMed ID: 23899625
[TBL] [Abstract][Full Text] [Related]
6. Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders.
Pellicano C; Niccolini F; Wu K; O'Sullivan SS; Lawrence AD; Lees AJ; Piccini P; Politis M
J Neurol; 2015 Dec; 262(12):2653-61. PubMed ID: 26410743
[TBL] [Abstract][Full Text] [Related]
7. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
Payer DE; Guttman M; Kish SJ; Tong J; Strafella A; Zack M; Adams JR; Rusjan P; Houle S; Furukawa Y; Wilson AA; Boileau I
Mov Disord; 2015 Feb; 30(2):160-6. PubMed ID: 25641350
[TBL] [Abstract][Full Text] [Related]
8. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.
Rao H; Mamikonyan E; Detre JA; Siderowf AD; Stern MB; Potenza MN; Weintraub D
Mov Disord; 2010 Aug; 25(11):1660-9. PubMed ID: 20589879
[TBL] [Abstract][Full Text] [Related]
9. Impulse control disorders in Parkinson's disease: recent advances.
Voon V; Mehta AR; Hallett M
Curr Opin Neurol; 2011 Aug; 24(4):324-30. PubMed ID: 21725242
[TBL] [Abstract][Full Text] [Related]
10. Impulse control disorders are associated with lower ventral striatum dopamine D3 receptor availability in Parkinson's disease: A [
Pagano G; Molloy S; Bain PG; Rabiner EA; Ray Chaudhuri K; Brooks DJ; Pavese N
Parkinsonism Relat Disord; 2021 Sep; 90():52-56. PubMed ID: 34385007
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.
Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Weintraub D; Antonini A
Mov Disord; 2015 Apr; 30(5):688-95. PubMed ID: 25649923
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies.
Martini A; Dal Lago D; Edelstyn NMJ; Salgarello M; Lugoboni F; Tamburin S
Front Neurol; 2018; 9():1018. PubMed ID: 30568628
[No Abstract] [Full Text] [Related]
13. Impulse Control and Related Disorders in Parkinson's Disease.
Weintraub D; Claassen DO
Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
[TBL] [Abstract][Full Text] [Related]
14. Problematic Internet use in Parkinson's disease.
Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Lees A; Piccini P
Parkinsonism Relat Disord; 2014 May; 20(5):482-7. PubMed ID: 24582704
[TBL] [Abstract][Full Text] [Related]
15. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
Lopez AM; Weintraub D; Claassen DO
Semin Neurol; 2017 Apr; 37(2):186-192. PubMed ID: 28511259
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.
Hinkle JT; Mills KA; Perepezko K; Pontone GM
J Geriatr Psychiatry Neurol; 2022 May; 35(3):353-362. PubMed ID: 33622073
[TBL] [Abstract][Full Text] [Related]
17. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
Steeves TD; Miyasaki J; Zurowski M; Lang AE; Pellecchia G; Van Eimeren T; Rusjan P; Houle S; Strafella AP
Brain; 2009 May; 132(Pt 5):1376-85. PubMed ID: 19346328
[TBL] [Abstract][Full Text] [Related]
18. Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footing.
Meyer GM; Spay C; Laurencin C; Ballanger B; Sescousse G; Boulinguez P
Neurosci Biobehav Rev; 2019 Mar; 98():164-176. PubMed ID: 30639672
[TBL] [Abstract][Full Text] [Related]
19. Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson's disease.
Maggi G; Loayza F; Vitale C; Santangelo G; Obeso I
J Neurol; 2024 May; 271(5):2798-2809. PubMed ID: 38416170
[TBL] [Abstract][Full Text] [Related]
20. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management.
Wu K; Politis M; Piccini P
Postgrad Med J; 2009 Nov; 85(1009):590-6. PubMed ID: 19892894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
